Pharmacovigilance Market by Product Type, Distribution Channel, End User 2022-2027

1
Global Pharmacovigilance Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Pharmacovigilance Market Research Report
2022-2027 According to the latest report by
IMARC Group, titled "Pharmacovigilance Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2022-2027," the global
pharmacovigilance market size reached US 6.7
Billion in 2021. Pharmacovigilance (PV) is the
pharmacological science of studying the
detection, assessment, and prevention of
unfavorable effects of pharmaceutical medicines.
It plays a critical role in identifying
previously unknown ADR (adverse drug reactions)
and drug toxicity, determining changes in
frequency or severity, and assessing the risks
and benefits of drugs to determine required
actions. It also assures the accuracy of
communicated information to healthcare
professionals and patients. As a result, PV is
widely used to comprehend the effects of drugs on
individuals across the globe. Request for a PDF
sample of this report https//www.imarcgroup.com/
pharmacovigilance-market/requestsample

4
Report Description and Highlights
Report Description
Global Pharmacovigilance Market Trends The
market is primarily driven by the rising
prevalence of chronic diseases, such as diabetes,
hypertension, oncological diseases, and cardiac
disorders, resulting in the increasing
consumption of drugs worldwide. In addition, the
introduction of advanced platforms to ensure
automated ADR reporting is contributing to market
growth. Moreover, the sudden outbreak of
coronavirus disease (COVID-19) and the consequent
necessity for vaccination has also created
several opportunities for the market players.
This, coupled with the widespread adoption of new
technologies in clinical research, such as the
incorporation of virtual services in the clinical
trial protocol, is augmenting the market growth.
Besides this, leading companies are undertaking
various initiatives to conduct clinical trials
and generate awareness about the proper
utilization of medicines, which is facilitating
the market growth. Along with this, extensive
research and development (RD) activities
conducted by major pharmaceutical and
biotechnological companies to develop new drugs
are providing a positive thrust to the market
growth. Looking forward, IMARC Group expects the
market value to reach US 11.8 Billion by 2027,
exhibiting a CAGR of 10.5 during the forecast
period (2022-2027). View Report TOC, Figures and
Tables https//www.imarcgroup.com/pharmacovigilan
ce-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Service Provider
• In-house
• Contract Outsourcing
•  
• Breakup by Product Life Cycle
• Pre-clinical
• Phase I
• Phase II
• Phase III
• Phase IV
• Breakup by Type
• Spontaneous Reporting
• Intensified ADR Reporting
• Targeted Spontaneous Reporting
• Cohort Event Monitoring
• EHR Mining

6
Report Description and Highlights
Report Description

• Breakup by Process Flow
• Case Data Management
• Case Logging
• Case Data Analysis
• Medical Reviewing and Reporting
• Signal Detection
• Adverse Event Logging
• Adverse Event Analysis
• Adverse Event Review and Reporting
• Risk Management System
• Risk Evaluation System
• Risk Mitigation System
•  
• Breakup by Therapeutic Area
• Oncology
• Neurology
• Cardiology
• Respiratory Systems
• Others

7
Report Description and Highlights
Report Description

•  
• Breakup by End Use
• Pharmaceuticals Companies
• Biotechnology Companies
• Medical Device Companies
• Others
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
•  

8
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Accenture plc
• ArisGlobal LLC
• BioClinica Inc. (Cinven Partners LLP)
• Capgemini
• Cognizant
• International Business Machines Corporation
• ICON plc
• IQVIA Inc
• ITClinical
• Parexel International Corporation
• Wipro Limited
•  

9
Key Questions Answered in the Report
Report Description

• How has the global pharmacovigilance market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global pharmacovigilance market?
• What are the key regional markets?
• What is the breakup of the market based on the
  service provider?
• What is the breakup of the market based on the
  product life cycle?
• What is the breakup of the market based on the
  type?
• What is the breakup of the market based on the
  process flow?
• What is the breakup of the market based on the
  therapeutic area?
• What is the breakup of the market based on the
  end use?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global
  pharmacovigilance market and who are the key
  players?
• What is the degree of competition in the
  industry?
•  

10
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Pharmacovigilance
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

11
Table of Contents
Report Description
6    Market Breakup by Service Provider    6.1
   In-house        6.1.1 Market Trends       
6.1.2 Market Forecast    6.2    Contract
Outsourcing        6.2.1 Market Trends       
6.2.2 Market Forecast7    Market Breakup by
Product Life Cycle    7.1    Pre-clinical     
  7.1.1 Market Trends        7.1.2 Market
Forecast      7.1    Phase I        7.1.1
Market Trends        7.1.2 Market Forecast    
7.1    Phase II        7.1.1 Market Trends     
  7.1.2 Market Forecast        Click here to
visit the complete table of content with list of
figures and tables https//www.imarcgroup.com/pha
rmacovigilance-market/toc

12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
14
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
15

Contact Us